Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
about
Clinical relevance of genetic polymorphisms in the human CYP2C subfamilyPrediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability.Summary of information on human CYP enzymes: human P450 metabolism data.CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Cytochromes P450: a structure-based summary of biotransformations using representative substrates.Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors.Enantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes.Cytochrome P450 enzymes contributing to demethylation of maprotiline in man.Importance of cytochromes in cyclization reactions: quantum chemical study on a model reaction of proguanil to cycloguanil.The potential of Hypoxis hemerocallidea for herb-drug interaction.Fast Prediction of Cytochrome P450 Mediated Drug Metabolism
P2860
Q28362533-B0B9C55C-C34F-496C-AF1E-4A5CABF40329Q31044030-EF03D432-402B-45C1-AE27-819DC9D0462CQ32103802-B81B6582-7E95-43AF-B110-28E89EEAFA58Q34302849-9E70AC39-8BBC-42F1-858A-98826F8F58E9Q34323195-3394C485-CB99-4330-834D-742B7DA719E6Q34367117-414F6362-4245-4B9A-8093-DF47E0E139E7Q34430456-8698D155-948D-4917-927C-F94FA6EF9C89Q35015993-FC15A77F-2BC7-4C23-93A8-46178A58257BQ37079954-3935E299-9412-47B2-A8DE-4F7DBF3457D0Q37278622-43483230-7F17-4C14-B128-4C5B6B081334Q40529215-8A62D649-9611-44AE-A1CD-EBC2CA702147Q41692485-E671ECC8-C980-488B-B4F5-EEC25A3F577EQ44032593-BE1C613A-9996-498E-8718-C41BD9FC5519Q46842312-39700867-F098-4CD3-BC16-5E98172A70F2Q46856531-ABF0B9DF-76AA-4CEF-82DD-78A26E62838BQ56975711-C3E7133E-7113-455B-B0AB-521D7808403B
P2860
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@ast
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@en
type
label
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@ast
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@en
prefLabel
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@ast
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@en
P2093
P2860
P1476
Comparison of (S)-mephenytoin ...... ution of several CYP isoforms.
@en
P2093
A A Somogyi
J K Coller
P2860
P304
P356
10.1046/J.1365-2125.1999.00005.X
P407
P577
1999-08-01T00:00:00Z